salmeterol xinafoate has been researched along with Airway Obstruction in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aumann, JL; Cornelissen, PJ; Janssens, E; Mueller, A; Smeets, JJ; van Noord, JA; Zaagsma, J | 1 |
Altraja, A; Halme, M; Karjalainen, EM; Kava, T; Laitinen, A; Laitinen, LA; Lindqvist, A; Pulkkinen, M | 1 |
Cazzola, M; Matera, MG | 1 |
Bos, AB; Hop, WC; Kerrebijn, KF; Verberne, AA | 1 |
Lundback, B; Palmer, JB; Rawlinson, DW | 1 |
Luce, P; Starke, ID | 1 |
Koëter, GH; Postma, DS; van Zomeren, EH; Weersink, EJ | 1 |
Henrikson, SL; Rush, BR | 1 |
1 review(s) available for salmeterol xinafoate and Airway Obstruction
Article | Year |
---|---|
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Ethanolamines; Formoterol Fumarate; Half-Life; Humans; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate | 2003 |
7 trial(s) available for salmeterol xinafoate and Airway Obstruction
Article | Year |
---|---|
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Spirometry; Tiotropium Bromide; Treatment Outcome | 2010 |
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate.
Topics: Adult; Airway Obstruction; Albuterol; Androstadienes; Asthma; Biopsy; Bronchi; Cromolyn Sodium; Double-Blind Method; Eosinophils; Female; Fluticasone; Humans; Lung; Male; Middle Aged; Salmeterol Xinafoate | 2003 |
Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Child; Double-Blind Method; Female; Humans; Male; Methacholine Chloride; Respiratory Function Tests; Salmeterol Xinafoate; Survival Analysis | 1993 |
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Chemistry, Pharmaceutical; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Smoking; Time Factors | 1993 |
The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Bronchodilator Agents; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Salmeterol Xinafoate; Time Factors | 1996 |
Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Circadian Rhythm; Cognition; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Peak Expiratory Flow Rate; Psychometrics; Salmeterol Xinafoate; Treatment Outcome | 1997 |
Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Cross-Over Studies; Female; Horse Diseases; Horses; Lung; Male; Recurrence; Salmeterol Xinafoate; Treatment Outcome | 2001 |